Talk:Maturity-onset diabetes of the young

Latest comment: 5 years ago by Natureium in topic Figures in the table don't seem to add up


changes to Permanent and Transient Neonatal Diabetes

edit

Thanks to user:Lphilipson for contributing this. I would suggest using part of this to seed a new neonatal diabetes article. I removed the second paragraph because we don't need to explain details of any of the dozens of non-MODY types of diabetes in this article. Also, I changed the age to below 6 months to match current recommendations (I dont think there have been any cases past 4-5 months, have there?) alteripse 12:59, 23 February 2007 (UTC)Reply

A newly identified and potentially treatable form of monogenic diabetes is the neonatal diabetes caused by activating mutations of the KCNJ11 gene, which codes for the Kir6.2 subunit of the beta cell K ATP channel. This results in congenital impairment of insulin release but is almost always thought to be Type 1 diabetes. The insulin deficiency results in poor prenatal growth and intrauterine growth retardation with low birth weight. The diabetes is usually diagnosed in the first few months of life, mostly from 1-3 months of age and rarely up to about 8 months of age. Remarkably, this type of diabetes often responds well to sulfonylureas and insulin may not be necessary. Severe mutations in the KCNJ11 gene can cause both insensitivity to the sulfonylurea drugs and a syndrome of developmental delay and neurological features called the DEND syndrome. These are very rare conditions, appearing about 1/100,000 to 1/200,000 live births and account for about 1/1000 of Type 1 diabetes cases. Fewer than 5% of the cases assumed to exist have been diagnosed.
Transient neonatal diabetes has several causes, the most common being a chromosomal error called parental disomy of chromosome 6. The other subunit of the KATP channel, SUR1, is encoded by the ABCC8 gene, and mutations in this gene can also cause transient neonatal diabetes. All of these forms would be negative for the antibodies associated with Type 1 diabetes, such as anti-GAD, anti-IA2, and anti-islet cell antibodies.

response

edit

I am surprised you think that "most diabetes clinics in the world are testing" for these mutations. My impression is the most diabetes clinics have yet to hear of this! There have been at least 1 case each up to 7 and 8 months of age, and a new article has the record: 17 months with as)ymptomatic family members for the R176C mutation (Fletchner et al Diabetes Metab 2006;32:569-580)Lphilipson 06:07, 27 February 2007 (UTC)Reply

Go ahead and change the age limit, but I think the testing is still targeted at those with onset before 6 mos. As to being looked for, there have been presentations about this for the last 2 years at all the major diabetes meetings. Every time a pediatric endocrinologist does a diabetes update, we mention it. We have finally picked up our first case after looking for 2 years. I hope there are no longer any diabetes specialists who take care of children who havent heard of it by now! alteripse 09:09, 1 March 2007 (UTC)Reply

We should talk directly

edit

We should talk directly. Our center in Chicago now has 10 patients since August, and in my conversations with Andrew Hattersley a couple of weeks ago in France we agreed that there are not more than about 25 patients in the USA. His total is about 360 PND cases, with about 160 off insulin. We are actively working to identify new cases and uncover additional mutations. The case at 17 months by the way was mis-labeled - it was clearly not PND. Our average age remains about 3 months with most cases even earlier. We are about to launch a national registry to try and follow more of these cases - would love to include your case. My conversations with ped and adult endos continues to suggest that the information penetrance is less then we might hope - and some of them are very skeptical. My email address is Lphilipson

  • Don't post your email in public. If you look at my user page, you can send a direct email to me. I am checking your user page to see if your email is enabled and will post to you. alteripse 10:32, 6 April 2007 (UTC)Reply

why chinese sentence and reference were removed

edit

Cases of MODY in China appear to be largely unexplained by the genes associated with MODY in Western populations.[1]

  1. ^ Xu JY, Dan QH, Chan V; et al. (2005). "Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients". Eur. J. Hum. Genet. 13 (4): 422–7. doi:10.1038/sj.ejhg.5201347. PMID 15657605. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
This paper actually does not support this assertion. If you read the abstract, they used an obsolete definition of MODY that simply includes any pair of relatives with any non-type 1 diabetes of which one member was diagnosed before age 25. They found several cases of recognizable MODY and in several cases could not identify the genetic cause. As cases of ordinary type 2 were not excluded by their selection criteria, it doesn't look like their findings supported the sentence I removed. It can be re-inserted with better supporting evidence. alteripse (talk) 21:22, 22 November 2009 (UTC)Reply

Review

edit

There's 30 types of "monogenic diabetes" doi:10.1210/er.2015-1116. JFW | T@lk 14:09, 3 April 2016 (UTC)Reply

Figures in the table don't seem to add up

edit

Both MODY 2 and MODY 3 are described as associated with 30-70% of cases, which makes a total of more than 100%. --CopperKettle 19:17, 19 January 2019 (UTC)Reply

Or is could only add up to 60%. Natureium (talk) 20:06, 19 January 2019 (UTC)Reply